Fiduciary Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Buy
+213
New +$218K 0.14% 57
2026
Q1
Sell
-324
Closed -$348K 84
2025
Q4
$348K Buy
324
+4
+1% +$3.83K 0.14% 63
2025
Q3
$244K Buy
320
+68
+27% +$50.6K 0.1% 77
2025
Q2
$197K Sell
252
-12
-5% -$9.32K 0.19% 48
2025
Q1
$218K Buy
+264
New +$220K 0.19% 38

Other funds holding LLY

Fiduciary Wealth Partners's LLY Position: Q2 2026 in Review

Fiduciary Wealth Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 213 shares worth $255K. The stake represents 0.14% of the portfolio and ranks #57 among its holdings. This is a return to the name: Fiduciary Wealth Partners previously reported a position in LLY as recently as Q4 2025.

Fiduciary Wealth Partners first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $348K in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fiduciary Wealth Partners held 213 shares of Eli Lilly worth $255K as of Q2 2026.
  • Eli Lilly was a new Fiduciary Wealth Partners position in Q2 2026.
  • Eli Lilly made up 0.14% of Fiduciary Wealth Partners's portfolio in Q2 2026, its #57 holding.
  • Fiduciary Wealth Partners first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Fiduciary Wealth Partners's Eli Lilly position peaked at $348K in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fiduciary Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.